Jitske van den Bulk

4PUBLICATIONS
26CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 04, 2023
Neoantigen Targetability in Progressive Advanced Melanoma.

Jitske van den Bulk, Els M E Verdegaal, Manon van der Ploeg

|Feb 15, 2023
CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden.

Jitske van den Bulk, Manon van der Ploeg, Marieke E Ijsselsteijn

|Jan 11, 2023
γδ T cells are effectors of immunotherapy in cancers with HLA class I defects.

Natasja L de Vries, Joris van de Haar, Vivien Veninga

|Jun 08, 2018
Cancer immunotherapy: broadening the scope of targetable tumours.

Jitske van den Bulk, Els Me Verdegaal, Noel Fcc de Miranda

Pageof 1